IASO Biotherapeutics
Dr. Ren Chunli has served as Vice President of Regulatory Affairs at IASO since March 2021. Dr. Ren received her Ph.D. in Molecular Biology from the University of Southern California. Previously she held senior Regulatory Affairs positions at CStone, GSK, Roche and other leading companies with over 12 years of broad regulatory management expertise and IND/ NDA filings experiences spanning across biological and oncology products. She has led CStone’s team to complete more than 10 IND/NDA filings.
This person is not in the org chart
This person is not in any offices
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.